Healthcare and MedTech: How India Is Becoming a Global Hub
In an era where healthcare innovation is reshaping global economies, India is emerging as a powerhouse in the healthcare and MedTech sectors. With a burgeoning population of over 1.4 billion and a rapidly expanding middle class, the demand for advanced medical services and technologies has skyrocketed. India's healthcare market, valued at approximately US$ 98.98 billion in 2023, is projected to reach US$ 193.59 billion by 2032, growing at a CAGR of 8.0%. This growth is not just domestic; it's positioning India as a global hub for healthcare and MedTech, attracting patients, investors, and innovators from around the world.
As a member of PHDCCI (PHD Chamber of Commerce and Industry), we recognize the immense business potential in this sector. For enterprises in the healthcare and MedTech industries, India offers unparalleled opportunities for expansion, partnerships, and investment. This article delves into how India is becoming a global leader in healthcare and MedTech, supported by well-researched data and statistics. We'll explore market dynamics, key drivers, innovations, challenges, and the future outlook, ensuring a comprehensive view for businesses aiming to capitalize on MedTech in India and Indian healthcare growth.
The Current State of India's Healthcare and MedTech Sectors
India's healthcare landscape has evolved dramatically over the past decade, transitioning from a primarily reactive system to one focused on prevention, innovation, and global integration. The overall Indian healthcare market was valued at about US$180 billion in FY 2023 and is projected to grow at a CAGR of 12% to reach roughly US$320 billion by FY 2028. This expansion is fueled by rising incomes, increased health awareness, and the integration of technology, making India healthcare hub a reality.
The Indian medical devices market, valued at approximately US$19.11 billion in 2025, is on a trajectory to hit US$31.85 billion by 2034 (IMARC Group). This growth is not merely quantitative; it represents a qualitative leap from low-value consumables to sophisticated, high-tech diagnostic and surgical equipment.
Traditionally, India relied on imports for 70–80% of its medical device requirements. However, the narrative is changing. In 2025 alone, Indian exports reached 187 countries, showcasing the global acceptance of "Made in India" technology. From cardiac stents and ventilators to complex imaging systems like MRI and CT scanners, Indian manufacturers are now competing on the global stage with products that offer world-class quality at a fraction of the traditional cost.
Digital integration is a game-changer. The India digital health market was estimated at USD 14.50 billion in 2024 and is projected to reach US$ 106.97 billion by 2033, growing at a CAGR of 25.12%. HealthTech startups are at the forefront, with the market valued at US$6,500 million in 2024 and expected to reach US$78,374.3 million by 2033 at a CAGR of 28.67%. Innovations in AI, IoT, and cloud computing are driving 79% of MedTech startup advancements, with 63% of these digitally integrated.
Pharmaceuticals and biotech complement this ecosystem. India's pharma exports are set to grow 10- to 15-fold, reaching nearly US$350 billion by 2047. With over 200 USFDA-approved plants outside the U.S., India is a leader in generics, supplying 20% of global generics.
Government Initiatives Driving the Transformation
The Indian government plays a pivotal role in fostering MedTech in India through targeted policies and schemes. The Ayushman Bharat Digital Mission (ABDM) is a flagship initiative creating a national digital health ecosystem, including Health IDs, registries, and telemedicine platforms. This supports universal health coverage and has boosted digital adoption.
Production-Linked Incentive (PLI) Schemes: With a staggering total investment allocation of ₹1.97 Lakh Crores across the pharmaceutical and medical device sectors, the PLI scheme has been a game-changer. As of late 2025, over 19 green-field projects have been commissioned, enabling the domestic production of high-end devices like Linear Accelerators (LINAC) and Mammograms that were previously entirely imported.
PRIP Scheme (Promotion of Research and Innovation in Pharma-MedTech): Launched with an outlay of ₹5,000 crore, the PRIP scheme focuses on bridging the gap between academia and industry. By establishing Centers of Excellence (CoEs) at NIPERs and providing financial assistance to startups, the government is ensuring that the next generation of medical breakthroughs happens on Indian soil.
National Medical Devices Policy 2023: This policy serves as the north star for the industry, aiming to increase India's global market share and promote a culture of quality and safety.
The Rise of Medical Tourism in India
Medical tourism is a cornerstone of India's global healthcare appeal. Valued at US$7.69 billion in 2024, it's projected to reach US$14.31 billion by 2029. In 2024, an estimated 7.3 million medical tourists visited India, up from 6.1 million in 2023. Foreign tourist arrivals for medical purposes reached 504,000 in 2023, with a CAGR of 40% post-pandemic.
Patients from over 200 countries are drawn to India for its unique combination of:
Accredited Infrastructure: Over 40 JCI-accredited hospitals offering world-class surgical care.
Cost Efficiency: Specialized treatments, such as cardiovascular surgeries or orthopedic replacements, often cost 60–80% less than in Western nations.
Short Wait Times: Immediate access to specialists and advanced diagnostic procedures.
Holistic Healing: The integration of traditional systems like Ayurveda and Yoga with modern medicine provides a comprehensive wellness experience.
The Heal in India campaign promotes India as a hub, integrating AYUSH therapies. By 2030, the market could reach US$18 billion, generating jobs and revenue. For businesses, this means opportunities in hospitality, logistics, and MedTech services tailored to international patients.
From Volume to Value: The Shift in Pharma and Innovation
The Economic Survey 2025-26 highlights a significant pivot in the Indian pharmaceutical industry: a transition from a volume-driven approach to a value-driven approach. While India continues to meet 20% of the global generic demand, the focus has shifted toward:
Complex Generics and Biosimilars: Moving up the value chain to provide affordable alternatives for expensive biologic therapies.
Digital Health Integration: The integration of AI, 3D printing, and IoT in medical devices is no longer a futuristic concept but a current reality. For instance, the launch of India’s first Bluetooth-enabled Continuous Glucose Monitor (CGM) in 2025 signifies the country's prowess in wearable health tech.
Advanced Therapies: With the approval of indigenous CAR-T cell therapies, India is entering the elite league of nations capable of providing cutting-edge regenerative medicine.
PHDCCI’s Vision: Strengthening the Domestic Ecosystem
As a leading industry advocate, the PHD Chamber of Commerce and Industry (PHDCCI) plays a pivotal role in shaping a resilient healthcare ecosystem. The Chamber has been at the forefront of several critical industry missions:
Rationalizing Customs Duties: PHDCCI has consistently urged the government to address "inverted duty structures" where raw materials are taxed higher than finished products. By advocating for lower tariffs on essential components, the Chamber aims to make domestic manufacturing more competitive.
Patient Safety and Quality Control: PHDCCI has strongly supported the ban on illegal imports of refurbished medical devices. The Chamber believes that fostering a market for new, indigenous technology is essential for ensuring patient safety and encouraging local innovation.
Ease of Doing Business: Through regular engagement with the CDSCO and the Ministry of Health, PHDCCI facilitates a streamlined regulatory environment, ensuring that innovative products reach the market faster without compromising on safety.
Future Outlook: India as a Global Healthcare Leader
As we look toward the remainder of the decade, the momentum of the Indian Healthcare and MedTech sector is unmistakable. The convergence of $100 billion in potential market value and a growing reputation for high-tech innovation ensures that India will not only serve its 1.4 billion citizens but will also act as the "Healthcare Provider to the World."
The journey from a net importer to a global manufacturing and innovation hub is well underway. With continued investment in R&D, infrastructure like the Medical Device Parks in Rajkot and Uttar Pradesh, and the digital backbone provided by the Ayushman Bharat Digital Mission, India is truly becoming the heartbeat of global healthcare.
https://www.phdcci.in/2026/02/17/budget-reaction-healthcare/
Comments
Post a Comment